IFLR1000

Ardian acquisition of majority stake in Neopharmed Gentili

18/11/2018
Private acquisition
Select tab

Completed

18/11/2018

Overview:

  • French private equity firm Ardian has acquired a majority stake in Neopharmed Gentili, an Italian pharmaceutical company from Mediolanum Farmaceutici.

Rajeeb Gurung - Researcher

Jurisdictions:

France
Italy

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:
ADVANT Nctm

Party: Mediolanum Farmaceutici (Seller)

Lawyer: Pietro Zanoni

Giovannelli e Associati

Party: Ardian (Acquirer)

Lawyers: Alessandro Giovannelli, Fabrizio Scaparro

Related deals